As of April 18, 2025, Procaps Group (PROC) has a market cap of $0.11 billion USD. According to our data, Procaps Group is ranked No.7474 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 18, 2025 | $0.11 B |
-56.84%
|
Dec 31, 2024 | $0.26 B |
-42.51%
|
Dec 29, 2023 | $0.46 B |
-22.48%
|
Dec 30, 2022 | $0.59 B |
-46.15%
|
Dec 31, 2021 | $1.10 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Catalent
CTLT
|
$11.52 B |
0.000 M
|
![]() USA
|
![]() Lonza
LONN.SW
|
$47.69 B |
0.001 M
|
![]() Switzerland
|
![]() Lonza
LONN.SW
|
$47.69 B |
0.001 M
|
![]() Switzerland
|
![]() Thermo Fisher Scientific
TMO
|
$161.38 B |
-0.001 M
|
![]() USA
|
![]() Perrigo
PRGO
|
$3.46 B |
0.000 M
|
![]() Ireland
|
![]() Barclays
BCS
|
$52.55 B |
-0.001 M
|
![]() UK
|
![]() Fresenius
FRE.DE
|
$25.04 B |
-0.000 M
|
![]() Germany
|
![]() Aurobindo Pharma
AUROPHARMA.NS
|
$7.97 B |
-0.000 M
|
![]() India
|
![]() Sun Pharmaceutical
SUNPHARMA.NS
|
$49.20 B |
-0.001 M
|
![]() India
|
![]() Cipla
CIPLA.NS
|
$14.33 B |
2.378 M
|
![]() India
|
![]() Teva Pharmaceutical Industries
TEVA
|
$15.66 B |
0.000 M
|
![]() Israel
|
Market Cap | = | PROC Stock Price | * | PROC Shares Outstanding |
= | $1.39 | * | 0.11 B | |
= | $0.11 B |